The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALPHABET INC | CAP STK CL C | 02079K107 | 18,488,679 | 15,900 | SH | SOLE | 15,900 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 13,945,020 | 338,718 | SH | SOLE | 338,718 | 0 | 0 | ||
FREEPORT-MCMORAN INC | CL B | 35671D857 | 8,437,500 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
LIVEPERSON INC | COM | 538146101 | 6,949,397 | 305,468 | SH | SOLE | 305,468 | 0 | 0 | ||
PAYPAL HLDGS INC | COM | 70450Y103 | 10,722,880 | 112,000 | SH | SOLE | 112,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 8,865,606 | 308,691 | SH | SOLE | 308,691 | 0 | 0 | ||
SYNNEX CORP | COM | 87162W100 | 8,916,299 | 121,974 | SH | SOLE | 121,974 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 14,633,925 | 61,500 | SH | SOLE | 61,500 | 0 | 0 |